C 22 H 25 Br 2 Co 8 N 2 O4Cl, monoclinic, P21/c (no. 14), a = 7.8246(13) Å, b = 23.695(4) Å, c = 13.225(2) Å, β = 95.987(17)°, V = 2438.6(7) Å 3 , Z = 4, Rgt(F) = 0.0844,
[3], DIAMOND [4] C-C bond. Aromatic C-H distances were set to 0.93 Å and their U iso set to 1.2 times the Ueq of the parent atom.
Experimental details
All commercially available reagents were used as supplied. A mixture of 3-bromo-2-hydroxybenzaldehyde (0.094 mmol) and (+−)-1.2-cyclohexanediamin (0.047 mmol) was dissolved in 30 mL of methanol and stirred for 30 min at room temperature, then 0.1 g cobalt nitrate hexahydrate was added and afforded a orange solution. After this, the purple suspension was stirred at 60°C for 3 h and filtrated. The purple crystals of the title compound slowly appears after 2 weeks.
Discussion
Cobalt-based complexes are of interest because of their special biological and catalytic activities [5] [6] [7] [8] . In this field, a large number of Schiff-base ligands have been used [9, 10] . However related research about halogenated Schiff base cobalt complexes is still rare [11] [12] [13] . As a part of our current interest in Schiff base complexes, we report here a new Co(III) compound.
The title compound crystallizes in the monoclinic space group P21/c. Thus the unit cell contains the two racemic cationic monomer complexes [Co((+)-3-brsalcy)(CH 3 
